109.09USD+2.68%Mkt Cap: 23.73B USDP/E: —Last update: 2026-05-26
Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory …
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap23.73B USD
Enterprise Value23.26B USD
Revenue (TTM)819.56M USD
Gross Profit483.49M USD
Net Income (TTM)-1.28B USD
Revenue/Share3.947 USD
Last Price109.09 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.7K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)270.90
PEG1.09
EV/EBITDA-24.51
EV/Revenue28.38
P/S28.97
P/B33.65
EPS (TTM)-5.76
EPS (Forward)0.40
52W Range
65.5630% of range212.75
52W High212.75 USD
52W Low65.56 USD
Profitability
Gross Margin79.73%
Oper. Margin-65.46%
EBITDA Margin-115.80%
Profit Margin-210.54%
ROE-172.78%
ROA-56.38%
Growth
Revenue Growth229.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-935.01M USD
CapEx (TTM)32.56M USD
FCF Margin-73.97%
FCF Yield-2.55%
Net Debt-481.05M USD
Net Debt/EBITDA0.51
Balance Sheet
Debt/Equity0.73
Current Ratio4.47
Quick Ratio3.88
Book Value/Sh3.255 USD
Cash/Share5.645 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateMar 3, 2011
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)200.00 USD
Target Range140.00 USD – 243.00 USD
# Analysts21
Ownership
Shares Out.216.75M
Float198.31M
Insiders0.53%
Institutions105.28%
Short Interest
Short Ratio7.3d
Short % Float7.66%
Short % Out.6.79%
Shares Short14.71M
Short (prev mo.)13.76M
Technical
SMA 50137.98 (-20.9%)
SMA 200156.02 (-30.1%)
Beta0.89
S&P 52W Chg28.31%
Avg Vol (30d)3.25M
Avg Vol (10d)5.21M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—